Abstract:Background and aim: Human immunodeficiency virus (HIV) remains a significant global health challenge, with approximately 39 million people living with HIV worldwide as of 2022. Despite progress in antiretroviral therapy, achieving the UNAIDS "95-95-95" target to end the HIV epidemic by 2025 faces challenges, particularly in sub-Saharan Africa. The pursuit of an HIV vaccine is crucial, offering durable immunity and the potential to end the epidemic. Challenges in vaccine development include the lack of known immune correlates, suitable animal models, and HIV's high mutation rate. This study aims to explore the current state of HIV vaccine development, focusing on the challenges and innovative approaches being investigated. Methods: In writing this review, we conducted a search of medical databases such as PubMed, ResearchGate, Web of Science, Google Scholar, and Scopus. The exploration of messenger ribonucleic acid vaccines, which have proven successful in the SARS-CoV-2 pandemic, presents a promising avenue for HIV vaccine development. Understanding HIV-1's ability to infiltrate various bodily compartments, establish reservoirs, and manipulate immune responses is critical. Robust cytotoxic T lymphocytes and broadly neutralizing antibodies are identified as key components, though their production faces challenges. Innovative approaches, including computational learning and advanced drug delivery systems, are being investigated to effectively activate the immune system. Results and conclusions: Discrepancies between animal models and human responses have hindered the progress of vaccine development. Despite these challenges, ongoing research is focused on overcoming these obstacles through advanced methodologies and technologies. Addressing the challenges in HIV vaccine development is paramount to realizing an effective HIV-1 vaccine and achieving the goal of ending the epidemic. The integration of innovative approaches and a deeper understanding of HIV-1's mechanisms are essential steps toward this transformative breakthrough.

Bending the Curve Through Innovations to Overcome Persistent Obstacles in HIV Prevention and Treatment

HIV vaccination: Navigating the path to a transformative breakthrough-A review of current evidence

Advanced Therapies for Human Immunodeficiency Virus

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention

HIV Vaccine for Prevention and Cure, A Mission Possible.

Controlling the HIV/AIDS epidemic: current status and global challenges

HIV/AIDS Treatment & Prevention with Nano-Technology: A Review

Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects

New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs

Advancing towards HIV-1 remission: Insights and innovations in stem cell therapies

Opportunities and challenges in new HIV therapeutic discovery: what is the next step?

Translational eradication approaches

REVIEW OF HIV IN SUB-SAHARAN AFRICA: CURRENT SITUATION, OPPORTUNITIES AND CHALLENGES

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

Clinical trials and recent progress in HIV vaccine development

Progress in HIV-1 Vaccine Development.

Advancements in Cell-Based Therapies for HIV Cure

Current status of the small molecule anti-HIV drugs in the pipeline or recently approved

Recent Insights into the HIV/AIDS Pandemic

Current Scenario of HIV/AIDS, Treatment Options, and Major Challenges with Compliance to Antiretroviral Therapy